Studies have revealed that PBX3, the homologous family protein of PBX1, promoted the migration and invasion of glioblastoma and colorectal cancer via activation of the MAPK/ERK signaling pathway, which might bring new insights into the oncogenic role of PBX1 in NSCLC [58,59]. The gene discussed is PBX1; the disease is non-small cell lung carcinoma.